We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in... Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Show more
ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...
ATLANTA, March 28, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...
ATLANTA, March 21, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing the significant unmet needs of women worldwide with a broad portfolio...
-- In the severe male factor cohort, findings show 24% of women became pregnant after FemaSeed -- -- FemaSeed pregnancy rate by cycle was more than double historic intrauterine insemination (IUI...
-- CEO Kathy Lee-Sepsick and Chief Medical Officer James Liu to Join Jones Trading Analyst Catherine Novack in a Conversation on Current Treatment Options in Infertility Including FemaSeed® at 1PM...
-- Paving the way forward for the broader commercial availability of FemaSeed, an accessible, safe, and cost effective alternative to IVF -- -- Ongoing uncertainty following recent Alabama Supreme...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.04 | 3.07692307692 | 1.3 | 1.3699 | 1.22 | 195346 | 1.30130629 | CS |
4 | -0.26 | -16.25 | 1.6 | 1.84 | 1.22 | 437155 | 1.51229559 | CS |
12 | 0.52 | 63.4146341463 | 0.82 | 2.4 | 0.734 | 780884 | 1.59843535 | CS |
26 | 0.15 | 12.6050420168 | 1.19 | 2.4 | 0.734 | 790607 | 1.32479264 | CS |
52 | 0.5459 | 68.7444906183 | 0.7941 | 4.75 | 0.2479 | 3766460 | 1.81071059 | CS |
156 | -11.74 | -89.755351682 | 13.08 | 13.75 | 0.2479 | 1406603 | 1.9283767 | CS |
260 | -11.74 | -89.755351682 | 13.08 | 13.75 | 0.2479 | 1406603 | 1.9283767 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions